Bleichroeder LP — 13F Holdings & Portfolio
CIK 1781002 · latest 13F-HR filed 2026-08-13
Bleichroeder LP manages $558.9M in 13F-reported U.S. long-equity assets across 78 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are GLD (31.31%), GPGI (11.26%), SPY (9.04%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 9 new positions and exited 12; 34 existing positions rose in reported value and 23 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Loading holdings…
AUM
$558.9M
Long-equity book
Holdings
78
Distinct positions
Period
2026-06-30
Filed 2026-08-13
Q/Q Activity
+9 / −12 / ↑34 / ↓23
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q2 26GLD31.3% · 0%GPGI11.3% · +0%SPY9.0% · 0%RHLD8.1% · 0%LIN5.6% · -12%DUOT3.5% · 0%DTIL2.8% · +21%CUE2.1% · -95%BX1.9% · 0%IMMX1.8% · 0%IDN1.5% · -1%SPGI1.5% · 0%INVE1.3% · 0%LIQT1.0% · +116%KZIA1.0% · 0%COCH0.9% · 0%CGEM0.8% · +150%WELL0.8% · 0%EYPT0.8% · 0%FLNT0.8% · -20%GNLX0.7% · 0%PROK0.7% · 0%COGT0.7% · newQQQ0.6% · 0%JPM0.6% · -32%MDXH0.5% · 0%IRD0.5% · 0%TV0.5% · 0%BRFH0.5% · 0%DMAC0.5% · 0%ROC0.5% · 0%SPIR0.4% · newIPWR0.4% · +33%NMTC0.4% · -83%CRIS0.4% · 0%RVMDW0.3% · 0%PROF0.3% · 0%RNXT0.3% · 0%MODD0.3% · +80%VENU0.2% · 0%TLPH0.2% · 0%QTI0.2% · +90%LLYVK0.2% · 0%DETX0.2% · newRNTX0.2% · newOWLT0.2% · 0%SINT0.2% · newCLRB0.1% · +189%MAIA0.1% · 0%FEAM0.1% · -8%PXLW0.1% · -58%ICCC0.1% · -51%LLYVA0.1% · 0%BEAT0.1% · newPHYS0.1% · 0%NSRX0.1% · 0%BNY0.1% · newLION0.0% · 0%PYPL0.0% · 0%CDNS0.0% · 0%
Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q1 26 → Q2 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
4 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 77.5%Cumulative share of the portfolio held in the largest N positions.
Firm Profile & Key People
As of the firm’s regulatory filing dated Sep 23, 2026.
Assets Under Management
$2.43B
Discretionary
$2.43B
Employees
12
Accounts
57
Address
1345 AVENUE OF THE AMERICAS
47TH FLOOR
NEW YORK, NY 10105
47TH FLOOR
NEW YORK, NY 10105
Phone
(212) 984-3815
Website
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| BLEICHROEDER HOLDINGS LLC Control | GENERAL PARTNER since Jul 2019 | 75% or more | Domestic Entity |
| GUNDLACH, ANDREW, STEPHEN Control | CHAIRMAN AND CHIEF EXECUTIVE OFFICER since Mar 2025 | Less than 5% | Individual |
| TASHBEKOV, DANIIAR | CHIEF COMPLIANCE OFFICER since Sep 2026 | Less than 5% | Individual |
| ASG 2019 IRRV TR Control Indirect owner via BLEICHROEDER HOLDINGS LLC | MEMBER since Jul 2019 | 75% or more | Domestic Entity |
| GUNDLACH, ANDREW, STEPHEN Control Indirect owner via ASG 2019 IRRV TR | TRUSTEE since Jul 2019 | General partner, trustee or manager | Individual |
Ownership & leadership changes · 3 filings with changes since Jul 15, 2019
From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.
Sep 23, 2026 filing
- AddedTASHBEKOV, DANIIAR · CHIEF COMPLIANCE OFFICER · Less than 5%
- ChangedGUNDLACH, ANDREW, STEPHEN · title CHAIRMAN AND CHIEF EXECUTIVE OFFICER / CHIEF COMPLIANCE OFFICER → CHAIRMAN AND CHIEF EXECUTIVE OFFICER
Mar 28, 2025 filing
- No longer listedKELLEN, MICHAEL, MAX · TRUSTEE · General partner, trustee or manager · indirect via ASG 2019 IRRV TR · control person · listed since Jul 2019
- No longer listedKELLEN, MICHAEL, MAX · TRUSTEE · General partner, trustee or manager · indirect via NINA GORRISSEN 2014 TRUST · control person · listed since Nov 2014
- No longer listedKELLEN, MICHAEL, MAX · CHAIRMAN AND CO-CEO · Less than 5% · control person · listed since Jul 2019
- No longer listedKellen, Caroline, L. · TRUSTEE · General partner, trustee or manager · indirect via NINA GORRISSEN 2014 TRUST · control person · listed since Nov 2014
- No longer listedKellen, Christopher, N. · TRUSTEE · General partner, trustee or manager · indirect via NINA GORRISSEN 2014 TRUST · control person · listed since Nov 2014
- No longer listedNINA GORRISSEN 2014 TRUST · MEMBER · 50–75% · indirect via BLEICHROEDER HOLDINGS LLC · control person · listed since Jul 2019
- ChangedASG 2019 IRRV TR · indirect via BLEICHROEDER HOLDINGS LLC: ownership 50–75% → 75% or more
- ChangedGUNDLACH, ANDREW, STEPHEN · title PRESIDENT, CO-CEO AND CHIEF COMPLIANCE OFFICER → CHAIRMAN AND CHIEF EXECUTIVE OFFICER / CHIEF COMPLIANCE OFFICER
Sep 4, 2020 filing
- No longer listedASG 2019 IRRV TR · LIMITED PARTNER · 50–75% · control person · listed since Jul 2019
- No longer listedNINA GORRISSEN 2014 TRUST · LIMITED PARTNER · 50–75% · control person · listed since Jul 2019
- ChangedASG 2019 IRRV TR · indirect via BLEICHROEDER HOLDINGS LLC: ownership General partner, trustee or manager → 50–75%
- ChangedBLEICHROEDER HOLDINGS LLC · ownership Less than 5% → 75% or more
- ChangedNINA GORRISSEN 2014 TRUST · indirect via BLEICHROEDER HOLDINGS LLC: ownership General partner, trustee or manager → 50–75%
Jul 15, 2019 filing (earliest on record)
- ListedASG 2019 IRRV TR · MEMBER · General partner, trustee or manager · indirect via BLEICHROEDER HOLDINGS LLC · control person
- ListedASG 2019 IRRV TR · LIMITED PARTNER · 50–75% · control person
- ListedBLEICHROEDER HOLDINGS LLC · GENERAL PARTNER · Less than 5% · control person
- ListedGUNDLACH, ANDREW, STEPHEN · PRESIDENT, CO-CEO AND CHIEF COMPLIANCE OFFICER · Less than 5% · control person
- ListedGUNDLACH, ANDREW, STEPHEN · TRUSTEE · General partner, trustee or manager · indirect via ASG 2019 IRRV TR · control person
- ListedKELLEN, MICHAEL, MAX · TRUSTEE · General partner, trustee or manager · indirect via ASG 2019 IRRV TR · control person
- ListedKELLEN, MICHAEL, MAX · TRUSTEE · General partner, trustee or manager · indirect via NINA GORRISSEN 2014 TRUST · control person
- ListedKELLEN, MICHAEL, MAX · CHAIRMAN AND CO-CEO · Less than 5% · control person
- ListedKellen, Caroline, L. · TRUSTEE · General partner, trustee or manager · indirect via NINA GORRISSEN 2014 TRUST · control person
- ListedKellen, Christopher, N. · TRUSTEE · General partner, trustee or manager · indirect via NINA GORRISSEN 2014 TRUST · control person
- ListedNINA GORRISSEN 2014 TRUST · LIMITED PARTNER · 50–75% · control person
- ListedNINA GORRISSEN 2014 TRUST · MEMBER · General partner, trustee or manager · indirect via BLEICHROEDER HOLDINGS LLC · control person
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- DUOS TECHNOLOGIES GROUP INC$8.4M +74.9%
- PRECISION BIOSCIENCES INC$6.7M +73.5%
- STATE STR SPDR S&P 500 ETF T$6.5M +14.8%
- CULLINAN THERAPEUTICS INC$3.1M +220.4%
- KAZIA THERAPEUTICS LTD$2.7M +89.2%
Top Trims
- SPDR GOLD TR-$29.4M -14.4%
- MDXHEALTH SA-$13.9M -82.1%
- INTELLICHECK MOBILISA INC-$6.1M -41.8%
- RESOLUTE HLDGS MGMT INC-$5.6M -10.9%
- GPGI INC-$4.9M -7.3%
New Positions
- CUE BIOPHARMA INC$11.7M
- COGENT BIOSCIENCES INC$3.9M
- SPIRE GLOBAL INC$2.5M
- NEUROONE MED TECHNOLOGIES CO$2.0M
- LIBERTY DEFENSE HLDGS LTD$1.1M
Exited Positions
- NEUROONE MED TECHNOLOGIES CO$3.1M
- CUE BIOPHARMA INC$1.6M
- PRECISION OPTICS CORP INC MA$1.2M
- RTX CORPORATION$1.2M
- SHARONAI HOLDINGS INC$568.2K
Bleichroeder LP Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | SPDR GOLD TR | GLD | 78463V107 | $175.0M | 31.31% | 475,000 | SH |
| 2 | GPGI INC | GPGI | 20459V105 | $63.0M | 11.26% | 3,972,176 | SH |
| 3 | STATE STR SPDR S&P 500 ETF T | SPY | 78462F103 | $50.5M | 9.04% | 67,645 | SH |
| 4 | RESOLUTE HLDGS MGMT INC | RHLD | 76134H101 | $45.4M | 8.12% | 314,166 | SH |
| 5 | LINDE PLC | LIN | G54950103 | $31.4M | 5.61% | 60,434 | SH |
| 6 | DUOS TECHNOLOGIES GROUP INC | DUOT | 266042407 | $19.5M | 3.49% | 1,627,806 | SH |
| 7 | PRECISION BIOSCIENCES INC | DTIL | 74019P207 | $15.9M | 2.84% | 2,018,190 | SH |
| 8 | CUE BIOPHARMA INC | CUE | 22978P205 | $11.7M | 2.09% | 370,682 | SH |
| 9 | BLACKSTONE INC | BX | 09260D107 | $10.7M | 1.91% | 90,750 | SH |
| 10 | IMMIX BIOPHARMA INC | IMMX | 45258H106 | $10.3M | 1.84% | 1,000,000 | SH |
| 11 | INTELLICHECK MOBILISA INC | IDN | 45817G201 | $8.4M | 1.51% | 2,056,343 | SH |
| 12 | S&P GLOBAL INC | SPGI | 78409V104 | $8.1M | 1.46% | 20,000 | SH |
| 13 | IDENTIV INC | INVE | 45170X205 | $7.3M | 1.30% | 2,884,495 | SH |
| 14 | LIQTECH INTL INC | LIQT | 53632A300 | $5.8M | 1.05% | 6,882,239 | SH |
| 15 | KAZIA THERAPEUTICS LTD | KZIA | 48669G303 | $5.6M | 1.01% | 400,000 | SH |
| 16 | ENVOY MEDICAL INC | COCH | 29415V109 | $5.0M | 0.89% | 6,250,000 | SH |
| 17 | CULLINAN THERAPEUTICS INC | CGEM | 230031106 | $4.6M | 0.81% | 250,000 | SH |
| 18 | WELLTOWER INC | WELL | 95040Q104 | $4.5M | 0.81% | 20,000 | SH |
| 19 | EYEPOINT INC | EYPT | 30233G209 | $4.5M | 0.81% | 316,515 | SH |
| 20 | FLUENT INC | FLNT | 34380C201 | $4.3M | 0.76% | 1,142,857 | SH |
| 21 | GENELUX CORPORATION | GNLX | 36870H103 | $4.2M | 0.74% | 1,380,666 | SH |
| 22 | PROKIDNEY CORP | PROK | 74291D104 | $4.1M | 0.73% | 2,000,000 | SH |
| 23 | COGENT BIOSCIENCES INC | COGT | 19240Q201 | $3.9M | 0.69% | 100,000 | SH |
| 24 | INVESCO QQQ TR | QQQ | 46090E103 | $3.4M | 0.61% | 4,640 | SH |
| 25 | JPMORGAN CHASE & CO | JPM | 46625H100 | $3.3M | 0.60% | 10,200 | SH |
| 26 | MDXHEALTH SA | MDXH | B5950S113 | $3.0M | 0.54% | 7,378,333 | SH |
| 27 | OPUS GENETICS INC | IRD | 67577R102 | $3.0M | 0.54% | 736,842 | SH |
| 28 | GRUPO TELEVISA S A B | TV | 40049J206 | $2.8M | 0.50% | 1,030,000 | SH |
| 29 | BARFRESH FOOD GROUP INC | BRFH | 067532200 | $2.8M | 0.50% | 1,390,758 | SH |
| 30 | DIAMEDICA THERAPEUTICS INC | DMAC | 25253X207 | $2.7M | 0.48% | 382,317 | SH |
| 31 | RANK ONE COMPUTING CORP | ROC | 753040104 | $2.6M | 0.47% | 500,000 | SH |
| 32 | SPIRE GLOBAL INC | SPIR | 848560306 | $2.5M | 0.45% | 135,000 | SH |
| 33 | IDEAL PWR INC | IPWR | 451622203 | $2.1M | 0.38% | 400,000 | SH |
| 34 | NEUROONE MED TECHNOLOGIES CO | NMTC | 64130M308 | $2.0M | 0.36% | 666,666 | SH |
| 35 | CURIS INC | CRIS | 231269309 | $2.0M | 0.36% | 3,802,329 | SH |
| 36 | REVOLUTION MEDICINES INC | RVMDW | 76155X118 | $1.9M | 0.34% | 200,000 | SH |
| 37 | PROFOUND MED CORP | PROF | 74319B502 | $1.7M | 0.30% | 254,753 | SH |
| 38 | RENOVORX INC | RNXT | 75989R107 | $1.6M | 0.29% | 1,666,098 | SH |
| 39 | MODULAR MED INC | MODD | 60785L306 | $1.5M | 0.27% | 336,986 | SH |
| 40 | VENU HLDG CORP | VENU | 92333E104 | $1.4M | 0.24% | 600,000 | SH |
| 41 | TALPHERA INC | TLPH | 00444T209 | $1.3M | 0.24% | 1,307,787 | SH |
| 42 | QT IMAGING HLDGS INC | QTI | 746962307 | $1.3M | 0.23% | 316,667 | SH |
| 43 | LIBERTY LIVE HOLDINGS INC | LLYVK | 530909308 | $1.2M | 0.21% | 13,802 | SH |
| 44 | LIBERTY DEFENSE HLDGS LTD | DETX | 53044R867 | $1.1M | 0.20% | 277,777 | SH |
| 45 | REIN THERAPEUTICS INC | RNTX | 00887A204 | $1.0M | 0.19% | 1,000,000 | SH |
| 46 | OWLET INC | OWLT | 69120X206 | $987.3K | 0.18% | 172,000 | SH |
| 47 | SINTX TECHNOLOGIES INC | SINT | 829392703 | $978.0K | 0.17% | 523,013 | SH |
| 48 | CELLECTAR BIOSCIENCES INC | CLRB | 15117F880 | $802.5K | 0.14% | 288,679 | SH |
| 49 | MAIA BIOTECHNOLOGY INC | MAIA | 552641102 | $720.0K | 0.13% | 500,000 | SH |
| 50 | 5E ADVANCED MATERIALS INC | FEAM | 33830Q208 | $637.7K | 0.11% | 458,774 | SH |
Filing History
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-13 | $558.9M | 78 | 0001420506-26-001619 |
| 2026-03-31 | 2026-05-14 | $578.6M | 81 | 0001420506-26-001007 |
| 2025-12-31 | 2026-02-13 | $568.3M | 73 | 0001420506-26-000412 |
| 2025-09-30 | 2025-11-14 | $513.0M | 72 | 0001420506-25-003432 |
Filer Information
Address
1345 AVENUE OF THE AMERICAS47TH FLOOR
NEW YORK, NY 10105
Phone
(917) 769-2999
Filing Manager
Bleichroeder LP
NEW YORK, NY
Signatory
Andrew Gundlach
Chairman and CEO of Bleichroeder LP